Low levels of vitamin D are known to nearly double the risk of cardiovascular disease in patients with diabetes, and researchers at Washington University School of Medicine in St. Louis now think they know why. They have found that diabetics deficient in vitamin D can't process cholesterol normally, so it builds up in their blood vessels, increasing the risk of heart attack and stroke. The new research has identified a mechanism linking low vitamin D levels to heart disease risk and may lead to ways to fix the problem, simply by increasing levels of vitamin D. "Vitamin D inhibits the uptake of cholesterol by cells called macrophages, " says principal investigator Carlos Bernal-Mizrachi, M.
Epocal, Inc., a leading edge provider of point of care technology, announced that it has received U.S. Food and Drug Administration (FDA) clearance to market its new glucose test on the epoc Blood Analysis System. Glucose measurements are used for the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus and idiopathic hypoglycemia, and of pancreatic islet cell tumors. The addition of glucose to the epoc BGEM Test Card, which includes in vitro diagnostic tests for pH, pO2, pCO2, Na, K, iCa and Hct (plus calculated values), further expands the clinical utility of the Company's point of care blood gas and electrolyte platform.
Axe Nutrition has a radically different approach to working with people who have diabetes, high blood pressure and/or high cholesterol. While the medical community focuses on giving people medication for the rest of their lives, and most other nutritionists limit the number of carbohydrates and calories people eat, Axe Nutrition focuses on recommending foods and dietary supplements which help the body rejuvenate itself, and reverse health issues. Axe Nutrition's program lasts only 90 days and is only a fraction of the cost of the seeing the average nutritionist. Telephone consultations allow them to work with clients all around the world.
An Investigation Into The Immune Response To Wheat Offers A Clue To The Elusive Cause Of Type 1 Diabetes
Scientists at the Ottawa Hospital Research Institute and the University of Ottawa have discovered what may be an important clue to the cause of type 1 diabetes. Dr. Fraser Scott and his team tested 42 people with type 1 diabetes and found that nearly half had an abnormal immune response to wheat proteins. The study is published in the August 2009 issue of the journal Diabetes. Early in life, the immune system is supposed to learn to attack foreign invaders such as viruses and bacteria, while leaving the body's own tissues and harmless molecules in the environment alone (including food in the gut). When this process goes awry, autoimmune diseases and allergies can develop.
Good news for people fearful of needles and squeamish of shots: Scientists at the 238th National Meeting of the American Chemical Society report the design of a painless patch that may someday render hypodermic needles - as well as annual flu shots - a thing of the past. Lined with tiny "microneedles, " these patches could make treatment of diabetes and a wide range of other diseases safer, more effective and less painful. Used as tiny hypodermic needles, they could improve treatment of macular degeneration and other diseases of the eye. "It's our goal to get rid of the need for hypodermic needles in many cases and replace them with a patch that can be painlessly and simply applied by a patient, " says Mark Prausnitz, Ph.
Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy. Their work, published in the August issue of The American Journal of Pathology, is the first to make the connection between eye disease and arginase, an enzyme known to be a player in cardiovascular disease, according to researchers at MCG and Charlie Norwood Veterans Affairs Medical Center. "The goal is to find a new strategy for preventing progression of diabetic retinopathy, " says Dr. Ruth Caldwell, a cell biologist at the MCG School of Medicine and VA Medical Center, and the study's corresponding author.